A 28-year-old man with community-acquired pneumonia caused by Haemophilus influenzae is being treated as an outpatient. He has no contraindications to oral therapy. What is the drug of choice for oral step-down treatment?

Explanation

## Oral Step-Down Therapy for H. influenzae Respiratory Infection **Key Point:** Amoxicillin-clavulanate is the preferred oral agent for step-down therapy in non-invasive H. influenzae infections (community-acquired pneumonia, bronchitis) because it covers both β-lactamase-producing and ampicillin-resistant strains. ### Why Amoxicillin-Clavulanate? 1. **Covers resistance mechanisms** — clavulanic acid inhibits β-lactamase, protecting amoxicillin from degradation 2. **Excellent oral bioavailability** — achieves therapeutic lung concentrations 3. **Cost-effective** — first-line oral agent in resource-limited settings 4. **Established efficacy** — standard for respiratory tract H. influenzae in outpatient management 5. **Lower resistance rates to combination** — resistance to amoxicillin-clavulanate is <5% in H. influenzae **High-Yield:** The addition of clavulanic acid restores amoxicillin activity against β-lactamase-producing H. influenzae, making it suitable for respiratory infections where invasive disease is not a concern. ### Oral Agents for H. influenzae: Comparison | Agent | Resistance Coverage | Indication | Limitation | |-------|-------------------|-----------|----------| | **Amoxicillin-clavulanate** | β-lactamase producers + BLNAR | CAP, bronchitis, otitis media | Rare ESBL resistance | | **TMP-SMX** | Broad spectrum | Alternative if allergy | GI upset; less preferred | | **Fluoroquinolone** | Excellent coverage | Respiratory infections | Reserve for resistant strains; cost | | **Cephalexin** | Limited (1st-gen) | Not recommended | Poor activity against BLNAR | **Clinical Pearl:** In outpatient CAP caused by H. influenzae, oral amoxicillin-clavulanate (625 mg three times daily) is preferred after initial IV therapy (ceftriaxone or cefotaxime) for 2–3 days or if mild-to-moderate disease from the start. **Mnemonic:** **ACE for Respiratory** — Amoxicillin-Clavulanate is the Entry-level oral choice for H. influenzae respiratory infections.